SCHEMBL6582037

SCHEMBL6582037

Clc1cc2c(cc1Cn1ccnc1-c1ccccc1)OCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.45
ESR1 P03372 1/20 0.42
SLC22A12 Q96S37 1/20 0.42
ADORA2A P29274 1/20 0.41
CACNA1F O60840 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
CACNA1D Q01668 1/20 0.41
CACNA1S Q13698 1/20 0.41
CACNA1C Q13936 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501419 0.80 KCNH2 (0.44) SLC22A12ADORA2AMEN1KMT2A
SCHEMBL11570953 0.80 BRD4 (0.45) BRD4ESR1HSD17B10MEN1KMT2A
SCHEMBL1349924 0.80 TP53 (0.40) SLC22A12ADORA2ACACNA1FOPRM1DRD3
SCHEMBL6161550 0.74 CYP2D6 (0.53) SLC22A12ADORA2A
SCHEMBL6582630 0.74 MEN1 (0.40) SLC22A12CACNA1FOPRM1DRD3OPRD1
SCHEMBL6159202 0.73 KCNH2 (0.48) SLC22A12ADORA2A
SCHEMBL9057464 0.73 SMN1; SMN2 (0.57) CACNA1FOPRM1DRD3OPRD1OPRK1
SCHEMBL17621 0.73 HSD17B10 (0.62) BRD4ESR1HSD17B10MEN1KMT2A
Hydrochloric Acid SCHEMBL233781 0.72 HSD17B10 (0.60) BRD4ESR1HSD17B10MEN1KMT2A
Iodide SCHEMBL28519464 0.72 HSD17B10 (0.60) BRD4ESR1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0804435-B1 NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA SA (FR) 2004-03-10 EP disclosed
US-5856509-A HYPOTENSIVE AGENTS ROUSSEL UCLAF (FR) 1999-01-05 US disclosed
EP-0804435-A1 NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ROUSSEL UCLAF (FR) 1997-11-05 EP disclosed
WO-1996004275-A1 NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ROUSSEL UCLAF (FR) 1996-02-15 WO disclosed